HPV vaccine after treatment for vulvar high-grade lesions
Treatments studied
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This trial tests whether getting the HPV vaccine after treatment for vulvar high-grade lesions can help prevent the lesions from coming back. It is for women who have not been vaccinated before and are about to have treatment for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 years or older
- You have a vulvar high-grade lesion (confirmed by a biopsy)
- You are scheduled for treatment (surgery, laser, or imiquimod cream)
- You have never had the HPV vaccine
- You do not have or have ever had HPV-related cancer (of the cervix, anus, or vulva)
- You are not pregnant, not allergic to the vaccine, and do not have HIV or a weakened immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a single dose of the HPV vaccine (Gardasil 9) can lower the amount of HPV virus in women who already have the virus, potentially reducing how easily it spreads. It will help us learn if vaccination can protect partners and communities.
This study tests if giving fewer doses of the HPV vaccine still protects against HPV-related cancers. It may help people who are willing to get a reduced number of shots.
This trial tests whether an HPV vaccine (Gardasil 9) can help women over 45 who still have HPV after treatment for a high-grade cervical lesion. It compares vaccinated and unvaccinated patients to see if vaccination lowers the risk of the lesion coming back.
This study tests how HPV antibodies work in urine samples from women with HPV16 before and after they get the HPV vaccine (Gardasil 9). It helps researchers understand how the vaccine protects against HPV.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
This Phase 3 study tests whether getting the HPV vaccine after a LEEP procedure helps prevent the cervical problem from coming back. You may be eligible if you had a high-grade cervical pre-cancer or very early cancer, and have not had an HPV vaccine before.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.